UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevention and management of secondary central nervous system lymphoma

Haematologica (Roma), 2023-03, Vol.108 (3), p.673-689

2023

Volltextzugriff (PDF)

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4111-4116

2012

Volltextzugriff (PDF)

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

BMC cancer, 2022-09, Vol.22 (1), p.971-9, Article 971

2022

Volltextzugriff (PDF)

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-09, Vol.12 (1), p.15805-10, Article 15805

2022

Volltextzugriff (PDF)

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-12, Vol.12 (1), p.21009-21009, Article 21009

2022

Volltextzugriff (PDF)

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2012-06, Vol.30 (18), p.2211-2217

2012

Volltextzugriff (PDF)

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

Bone marrow transplantation (Basingstoke), 2019-10, Vol.54 (10), p.1625-1631

2019

Volltextzugriff (PDF)

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Hematological oncology, 2019-12, Vol.37 (5), p.548-557

2019

Volltextzugriff (PDF)

Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma

AIDS (London), 2010-03, Vol.24 (6), p.851-856

2010

Volltextzugriff (PDF)

Use of Zidovudine and Interferon Alfa With Chemotherapy Improves Survival in Both Acute and Lymphoma Subtypes of Adult T-Cell Leukemia/Lymphoma

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4696-4701

2011

Volltextzugriff (PDF)

Management of primary and secondary CNS lymphoma

Hematological oncology, 2023-06, Vol.41 (S1), p.25-35

2023

Volltextzugriff (PDF)

EXABS-231-ABCL The Treatment of Primary and Secondary CNS Lymphoma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S119-S122

2023

Volltextzugriff (PDF)

How I treat secondary CNS involvement by aggressive lymphomas

Blood, 2023-11, Vol.142 (21), p.1771-1783

2023

Volltextzugriff (PDF)

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.54-54, Article 54

2023

Volltextzugriff (PDF)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Journal of personalized medicine, 2023-07, Vol.13 (7), p.1182

2023

Volltextzugriff (PDF)

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Blood, 2010-11, Vol.116 (22), p.4569-4577

2010

Volltextzugriff (PDF)

Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2192-2198

2009

Volltextzugriff (PDF)

Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

HemaSphere, 2024-06, Vol.8 (6), p.e89-n/a

2024

Volltextzugriff (PDF)

Evidence-based management of primary and secondary CNS lymphoma

Seminars in hematology, 2023-11, Vol.60 (5), p.313-321

2023

Volltextzugriff (PDF)

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

Journal of personalized medicine, 2021-08, Vol.11 (9), p.876

2021

Volltextzugriff (PDF)

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

HemaSphere, 2023-08, Vol.7 (S3), p.e2454568-n/a

2023

Volltextzugriff (PDF)

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

Blood, 2008-11, Vol.112 (9), p.3827-3834

2008

Volltextzugriff (PDF)

P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity

HemaSphere, 2022-10, Vol.6 (Suppl), p.7-8

2022

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)

Publikationsform

Sprache

Englisch
(182)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(102)
Humans
(93)
Hematology
(72)
Female
(41)
Middle Aged
(41)
Male
(40)
Adult
(39)
Lymphoma
(31)
Oncology
(30)
Aged
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Retrospective Studies
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Hematologic And Hematopoietic Diseases
(19)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(18)
Prognosis
(18)
Treatment Outcome
(18)
Central Nervous System Neoplasms - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(59)
British Journal Of Haematology
(28)
Journal Of Clinical Oncology
(8)
Clinical Lymphoma, Myeloma And Leukemia
(7)
Aids
(5)
The Lancet. Haematology
(5)
Blood Advances
(4)
Hemasphere
(4)
Hematological Oncology
(4)
Hiv Medicine
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Prevention and management of secondary central nervous system lymphoma

A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma

Use of Zidovudine and Interferon Alfa With Chemotherapy Improves Survival in Both Acute and Lymphoma Subtypes of Adult T-Cell Leukemia/Lymphoma

Management of primary and secondary CNS lymphoma

EXABS-231-ABCL The Treatment of Primary and Secondary CNS Lymphoma

How I treat secondary CNS involvement by aggressive lymphomas

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma

Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

Evidence-based management of primary and secondary CNS lymphoma

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity

Aktive Filter

Suchergebnisse filtern